Centre for Health Economics & Policy Innovation Report 2018–2019

Centre for Health Economics & Policy Innovation

Centre for Health Economics & Policy Innovation Centre Report 2018-19

Imperial College Business School

Page 1 of 16

Centre for Health Economics & Policy Innovation

Contents

CHEPI in context

3

Faculty

4

Research staff

6

Support

6

Our research projects

7

Publications by CHEPI faculty and research staff in 2018

12

Book chapters

13

Our programmes

14

Imperial College Business School

Page 2 of 16

CHEPI, February 2019

Centre for Health Economics & Policy Innovation

CHEPI in context Since its inception in 2016, and formal launch in 2017, the Centre for Health Economics & Policy Innovation (CHEPI) has grown rapidly to become a flagship research centre at Imperial College Business School.

The successful establishment of the Centre is the result of several years of strategic hires and concerted effort to develop strengths in an academic area that has a unique potential for academic collaborations and synergies across Imperial College. CHEPI’s growth enhances the research and innovation profile of the School within Imperial College and relative to its competitors.

Work on health at the Business School has taken many forms over the years, and the School’s commitment to a strong presence in the areas of health economics, policy and management has remained steadfast.

The School, and CHEPI, benefit from their proximity to the leading Faculty of Medicine and School of Public Health at Imperial College, as well as to the faculties of Engineering and Natural Sciences.

In less than three years, CHEPI’s team of 11 affiliated faculty, 15 postdoctoral and doctoral researchers, and its management team have achieved their initial goal of establishing the Centre as an authoritative and trusted player within Imperial College, and in a highly competitive national and international arena. They have also made the Centre financially sustainable, tripling its research income.

Faculty affiliated with CHEPI have been very successful in obtaining funding from a diverse portfolio of agencies, ranging from the European Commission, to charities such as the Health Foundation, research councils such as the ESRC, NIHR, Arts & Humanities Research Council, along with government agencies such as NHS England, Public Health England and the Department of Health.

This report provides a summary of key developments in CHEPI’s work over the past year. The Centre currently leads and is involved in multimillion pound cutting-edge research projects that build upon and leverage our strong collaborations with all faculties within Imperial College, and especially with the School of Public Health, the Department of Mathematics and the Data Science Institute. CHEPI’s research is designed to influence policy and encourage healthenhancing choices by people, business and government for the benefit of society. Of no less importance are collaborations with external partners, which have peaked in the past couple of years with the involvement and leadership of CHEPI in major international collaborations in the context of the Global Challenges Research Fund and of the EU’s Horizon 2020 programme.

CHEPI’s mission is to research incentives and environments that encourage individuals and organisations to make health-enhancing decisions

CHEPI supports the development of business and government policies that embed those incentives and create those environments

As a research centre, CHEPI excels in all four pillars of the Business School’s Strategic Vision 2018 to 2028. The Centre conducts worldrenowned research, published in leading journals, and influences policy at the highest levels; its faculty teach world class postgraduate programmes aimed at educating the next generation of health leaders and foster new researchers in their PhD candidates; CHEPI provides access to key resources in the form of data storage and processing environments; and, its extensive collaborations with academics in all faculties ensure that the Centre maximises the benefits afforded by being part of Imperial College London.

Imperial College Business School

Page 3 of 16

Centre for Health Economics & Policy Innovation

Faculty Prof. Franco Sassi Centre Director, Professor of International Health Policy & Economics Impacts of public policies to tackle major chronic diseases and their predisposing risk factors, including poor nutrition, physical inactivity, alcohol and tobacco use, environmental and social determinants.

Prof. James Barlow Professor of Technology & Innovation Management (Healthcare) Adoption, implementation and sustainability of innovation in healthcare systems.

Dr. Benita Cox Academic Director, MSc International Health Management

Dr. Katharina Hauck Reader in Health Economics (School of Public Health) Economics of HIV/AIDS, the impact of epidemics, the evaluation health interventions, and the role of behaviour in the transmission of infectious disease.

Dr. Marisa Miraldo Associate Professor in Health Economics Determinants of innovation in the pharmaceutical sector, determinants of the adoption and diffusion of innovation and on the impact of policy and regulation on pharmaceutical firm’s strategies.

Dr. Laure de Preux Assistant Professor Determinants of health, the evaluation of climate change related policies, and the impact of climate and pollution on health and the healthcare sector.

Imperial College Business School

Page 4 of 16

Centre for Health Economics & Policy Innovation

Prof. Carol Propper Professor of Economics (CBE, FBA International Fellow, NAM) Impact of incentives on the quality and productivity of healthcare, the effect of market incentives on the production of public services and the impact of environmental factors on health.

Dr. Pedro Rosa Dias Associate Professor of Health Economics Health economics in developing countries, inequalities in health and healthcare and the effects of educational policy on health outcomes.

Dr. Reza Skandari Assistant Professor of Health Operations Optimising healthcare design decisions, ranging from treatment plans to health policies.

Prof. Peter Smith Emeritus Professor of Health Policy Economic aspects of health systems, global health, and the productivity and public finance of health services.

CHEPI’s collaborations across Imperial College London ENGINEERING Aeronautics

Computing

Bioengineering

Dyson School of Design Engineering

Data Science Institute Institute for Molecular Science & Engineering

Materials

Chemical Engineering

Earth Science and Engineering

Mechanical Engineering

MEDICINE Civil & Environmental Engineering Electrical and Electronic Engineering Energy Futures Lab Institute for Security Science & Technology

Centre for Translational Nutrition & Food Research

Institute of Clinical Sciences

Mathematics

Physics

Centre for Environmental Policy Grantham

Imperial College Business School

National Heart and Lung Institute

School of Public Health CHEPI

Department of Surgery and Cancer

Lee Kong Chian School of Medicine

Academic Health Science Centre

Institute of Global Health Innovation

NATURAL SCIENCES

Chemistry

Department of Medicine

Imperial NHS Trust

Imperial Network for Vaccine Research

BUSINESS SCHOOL

Life Sciences

Economics & Public Policy

Management

Finance

CHEPI Analytics, Marketing & Operations

Page 5 of 16

Centre for Health Economics & Policy Innovation

Research staff Dr. Elisabetta Aurino

Ali Belabess

Imperial College Research Fellow

Research Associate

Dr. Tim Chambers

Dr. Dian Kusuma

Research Associate

Research Associate

Dr. Elisa Pineda

Dr. Carmen Huerta

Research Associate

Research Associate

Joint appointment with the Centre for Mathematics of Precision Healthcare

Joint appointment with the School of Public Health

Dr. Charlotte Vrinten Research Associate

Support Dr. Jack Olney

Ella Hattey

Centre Manager

Project Coordinator

Lorraine Sheehy

Rose Tudball

Centre Administrator

Programme Manager, MSc International Health Management

Imperial College Business School

Page 6 of 16

Centre for Health Economics & Policy Innovation

Our research projects Science & Technology in childhood Obesity Policy (STOP) PI: Prof. Franco Sassi (coordinating partner) Funder: European Commission (H2020 SC2) Duration: June 2018 – May 2022 The STOP project brings together a range of key health and food sector actors to generate scientifically sound and policy-relevant evidence on the factors that have contributed to the spread of childhood obesity in EuropeanScience and Technology in Countries. Over the course of four years the European Commission-funded consortium of 31 research, childhood advocacy and governmental organisations from 16 countries will posit alternative policy Obesity options to Policy address the problem.

STOP will expand and consolidate the multidisciplinary evidence base upon which effective and sustainable policies can be built to prevent and manage childhood obesity. STOP also aims at creating the conditions for evidence to translate into policy and for policy to translate into impacts on the ground.

The primary focus of STOP is on the cumulative impacts of multiple and synergistic exposures in vulnerable and socially disadvantaged children and their families, which must be a priority target for the fight against childhood obesity in Europe to reach a tipping point and succeed. STOP will identify critical stages in childhood (starting from prenatal exposures) at which interventions can be most effective and efficient.

Major health and food sector actors, including scientists, health professionals, government policy makers, national public health agencies, international organisations, civil society and business organisations are working together to establish mechanisms through which policy-relevant evidence can be generated, made available and used in the design and implementation of effective and sustainable solutions for the childhood obesity problem at the EU, National and local levels. The project has adopted a trans-disciplinary, multistakeholder and multi-sectoral (whole-of-government) approach, in a “Health-in-all-policies� framework. In the pursuit of the above goals, the project will benefit from the support and contributions of partners from non-European countries (United States and New Zealand), who will complement the expertise of European partners and share valuable experiences in addressing childhood obesity.

Imperial College Business School

Page 7 of 16

Centre for Health Economics & Policy Innovation

Empirical evidence on the impact of the labour market on the production of healthcare and health PI: Prof. Carol Propper Funder: European Research Council Duration: October 2018 – September 2022

What determines the quality of public services? How do shocks to the economy affect the delivery of public services? Why is there such variation in the efficiency of public service providers and how does this affect those who use their services?

The aim of this project is to fundamentally contribute to our understanding of the labour supply behaviour of public service providers and the impact of their behaviour on the quality and distribution of critical outcomes.

To achieve this we will primarily focus on the healthcare sector. The importance of the healthcare sector to social wellbeing, the existence of shocks that create ‘natural’ experiments, and the availability of large administrative datasets makes the healthcare market the ideal test-bed. Further, understanding how labour markets in healthcare operate is crucial for public expenditure and central because society cares about the output produced.

We will adopt two broad approaches. The first is to examine the micro-foundations of behaviour for critical agents. The second is to examine the effect of policy and macro shocks to the economy on the reallocation of labour within, and between, healthcare and other sectors. In all cases my focus is on understanding labour supply responses and how these impact on the level and distribution of critical outcomes in society.

The ideas are applicable to all labour markets characterised by high levels of investment in human capital and where market failures mean society cares about the outcomes. Our research will contribute to the fields of labour and health economics. Our research will also inform the development of policies to increase the uptake and spread of medical innovation, increase the quality of the medical labour force and improve the design of healthcare systems.

NIHR Global Health Research Unit on CVD and Diabetes in South Asians PI: Prof. John Chambers (FoM) Co-I’s: Prof. Franco Sassi & Dr Marisa Miraldo Funder: National Institute for Health Research (NIHR) Duration: June 2017 – March 2021

Heart disease and stroke (the main forms of “cardiovascular disease”) and diabetes (abnormally high blood sugars) are the world’s leading health problems. 18 million people die from cardiovascular diseases each year (1/3rd of all deaths), while 420 million people live with diabetes. The burden of cardiovascular disease and diabetes are especially high in South Asia, one of most densely populated regions in the world. India alone has ~62 million people living with cardiovascular disease and ~56 million with diabetes. Both diseases cause an enormous financial burden on individuals, their families and the societies they live in.

Cardiovascular disease and diabetes are thus important contributors to poverty, inequality and social instability. There is an urgent need to find new approaches to reducing the burden of these diseases, especially in South Asia Our Global Health Research Unit comes together as a close collaboration between experts at Imperial and leading academic and clinical institutions in Bangladesh, India, Pakistan and Sri Lanka.

Imperial College Business School

Page 8 of 16

Centre for Health Economics & Policy Innovation

Does childhood obesity hinder human capital development?

PI: Prof. Franco Sassi Funder: Health Foundation Duration: January 2018 – December 2021

To establish the causal pathways that link childhood obesity to human capital development and social outcomes, with a focus on educational attainment, labour market outcomes (employment, wages and sick leave) and indicators of civic participation in three UK cohorts.

The project will address an important set of research questions on the social and economic impacts of childhood obesity by leveraging some of the most detailed longitudinal data sources available in the UK as well as innovative approaches to assessing causality and the links between health and social outcomes. It will do so with a view to making an impact on the actins of key stakeholders involved in addressing the problem. In particular, the study will rely on two national cohort studies reflecting the lives of individuals born in 1958 and 1970, and on a local cohort study of children born in 1991-92 providing a unique set of information based on biomarkers, anthropometric measures, linkages with rich administrative data, along with more traditional survey questions. The study will leverage biomarkers in the latter cohort and genetic information in all three cohorts in a detailed investigation of the causal pathways that link children early life exposures and background socioeconomic status to their likelihood of developing obesity in young age, to the social and economic outcomes associated with childhood obesity. In particular, the study will focus on dimensions of human capital (education and cognitive skills) and returns to human capital, in the form of employment and earnings, as well as forms of civic participation and social engagement.

RARE2030 — a participatory foresight study for policy-making rare diseases Project Lead: European Organisation for Rare Diseases Association Co-I’s: Prof. Franco Sassi & Dr Marisa Miraldo Funder: European Commission Duration: January 2019 – December 2020

Building upon the success of European policy in support of rare diseases (RDs) to-date, we seek to use innovative research-based methods to best support future policy decisions for RDs. We seek to propose policy recommendations to guide this future policy by using the participatory foresight approach and additional innovative consensus building methods, encouraging broad and sustainable uptake by patients, all relevant stakeholders, (in particular policy makers) and society at large. By harnessing the expertise and experience of associated and collaborating project partners and an panel of experts made up of representatives of all those benefitting from the projects outcomes, we specifically seek to establish the baseline knowledge required to identify, agree on and rank scientific, technological, social, political, financial and institutional drivers for the future governance and care of RDs in Europe. By exploring and combining trends and existing instruments we intend to develop 3-5 consistent and plausible qualitative scenarios revealing the needs, perceptions and preferences of the RD Community and society at large as well as the policy options leading to these scenarios. Beneficiaries of this project include all stakeholders in the RD community comprised of a broad range of key target groups including healthcare professionals, researchers, industry, policy makers, patient organisations and the 30 million people living with RD and their families.

Imperial College Business School

Page 9 of 16

Centre for Health Economics & Policy Innovation

The Health, Economic and Social impact of ARTS engagement: a Public Health Study (HEARTS) Project Lead: Royal College of Music Co-I: Dr Marisa Miraldo Funder: Arts & Humanities Research Council Duration: June 2018 – January 2021

In the past few decades, there has been a surge of international interest in the role of the arts and culture in healthcare, public health and health promotion, on an individual and community level. However, the vast majority of research studies have focused on the effects of targeted, time-limited arts interventions on particular patient groups. Yet, much of the arts and cultural engagement across the UK is not confined to specific interventions but involves a more general, ubiquitous participation that can be harder to measure through experimental studies. A select number of public health studies have found associations between cultural participation (including attending concerts, museums and galleries) and self-reported health, as well as inverse associations between cultural participation and mortality risk. However, important questions remain, and to date, there have been no large-scale public health studies examining the impact of the arts in the UK. This project is led by the Centre for Performance Science, an internationally distinctive partnership of the Royal College of Music and Imperial College London, with an extensive track record in arts, health and social research. It explores the effect of (i) activities that involve actively ‘doing’ (e.g. music, dance, art, photography and drama) and (ii) activities that require physical attendance (e.g. attending concerts, monuments, museums, galleries, cinemas, heritage archives and theatre); (iii) ‘home-based’ activities (e.g. listening to the radio, watching TV, reading, storytelling, using arts-based apps, digital arts experiences, online music co-production). Our research questions identify the impact of the arts and culture on individual, social and economic measures of health and wellbeing, as well as explore how associations vary between different socioeconomic, geographical and ethnic populations within the UK.

Cost of Diseases and Multimorbidity Co-I’s: Prof. Franco Sassi & Dr Laure de Preux Funder: Public Health England Duration: May 2018 – October 2018

Multi-morbidity (MM) can be defined as the presence of 2 or more long-term medical conditions in one individual. It impacts quality of life, daily function, and results in greater healthcare utilisation, including emergency hospitalisations the more co-existing conditions one has. MM is potentially the biggest challenge facing the NHS with an estimated 1 in 4 older people having two or more long-term conditions or ‘multimorbidity’, especially given the ageing population. Yet, little is known about best practice for these patients, despite being the group with the highest impact on the NHS and with the worst outcomes.

Gaining a better understanding of how researchers have tackled this problem by reviewing the methods used, as well as understanding how multi-morbidity prevalence is set to change in England into the future and how much it is going to cost is vital if the NHS and social care are to be properly resourced. Such figures do not exist for England, nor is there consensus over the best approach.

The project will: • Review the literature and describe different costing methods for multi-morbidity; • Recommend the most appropriate costing method for estimating the annual cost per case of specific combinations of conditions; • Calculate the annual cost-per-case of a range of individual diseases and combinations of diseases, and analyse variation between the different costs.

Imperial College Business School

Page 10 of 16

Centre for Health Economics & Policy Innovation

Integrated improving access to psychological therapies (IAPT) early implementers programme PI: Prof. Carol Propper Funder: NHS England Duration: January 2017 – March 2018

Collaboration for Leadership in Applied Health Research and Care Northwest London (CLAHRC II) Project Lead: Chelsea & Westminster Hospital NHS Foundation Trust Co-I: Prof. James Barlow Funder: National Institute for Health Research (NIHR) Duration: January 2014 – December 2018

Network and competition effects in the diffusion of innovation in the NHS PI: Dr Marisa Miraldo Funder: Health Foundation Duration: April 2015 – June 2018

A robust assessment of the impact of short-term and local pollution variations on health outcomes PI: Dr Laure de Preux Funder: The Academy of Medical Sciences Duration: June 2017 – May 2019

The relationship between poor health and social mobility PI: Prof. Franco Sassi Funder: Social Mobility Commission Duration: June 2019 – March 2020

Imperial College Business School

Page 11 of 16

Centre for Health Economics & Policy Innovation

Publications by CHEPI faculty and research staff in 2018

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

Antonacci G, Reed JE, Lennox L, Barlow J. The use of process mapping in healthcare quality improvement projects. Health Services Management Research. 2018 May;31(2):74-84.

Schott W, Aurino E, Penny ME, Behrman JR. Adolescent mothers’ anthropometrics and grandmothers’ schooling predict infant anthropometrics in Ethiopia, India, Peru, and Vietnam. Annals of the New York Academy of Sciences. 2018 Mar;1416(1):86-106.

Aurino E, Schott W, Penny ME, Behrman JR. Birth weight and prepubertal body size predict menarcheal age in India, Peru, and Vietnam. Annals of the New York Academy of Sciences. 2018 Mar;1416(1):107-16.

Picchioni F, Aurino E, Aleksandrowicz L, Bruce M, Chesterman S, Dominguez-Salas P, Gersten Z, Kalamatianou S, Turner C, Yates J. Roads to interdisciplinarity–working at the nexus among food systems, nutrition and health. Food Security. 2017 Feb 1;9(1):181-9.

Bundy DA, de Silva N, Horton S, Patton GC, Schultz L, Jamison DT, Abubakara A, Ahuja A, Alderman H, Allen N, Appleby L, Aurino E. Investment in child and adolescent health and development: key messages from Disease Control Priorities. The Lancet.

2018 Feb 17;391(10121):687-99.

Azupogo F, Aurino E, Gelli A, Bosompem KM, Ayi I, Osendarp SJ, Brouwer ID, Folson G. Agro-ecological zone and farm diversity are factors associated with haemoglobin and anaemia among rural school-aged children and adolescents in Ghana. Maternal & Child Nutrition. 2019 Jan;15(1):e12643.

Aurino E, Morrow V. “Food prices were high, and the dal became watery”. Mixed-method evidence on household food insecurity and children’s diets in India. World Development. 2018 Nov 1;111:211-24.

Tranchant JP, Gelli A, Bliznashka L, Diallo AS, Sacko M, Assima A, Siegel EH, Aurino E, Masset E. The impact of food assistance on food insecure populations during conflict: Evidence from a quasi-experiment in Mali. World Development. 2018 Mar 3.

Huddy JR, Ni M, Misra S, Mavroveli S, Barlow J, Hanna GB. Development of the Point-of-Care Key Evidence Tool (POCKET): a checklist for multi-dimensional evidence generation in point-of-care tests. Clinical Chemistry and Laboratory Medicine (CCLM).

2018 Nov 9.

Myron R, French C, Sullivan P, Sathyamoorthy G, Barlow J, Pomeroy L. Professionals learning together with patients: An exploratory study of a collaborative learning Fellowship programme for healthcare improvement. Journal of Interprofessional Care.

2018 May 4;32(3):257-65.

Chatterjee A, Modarai M, Naylor NR, Boyd SE, Atun R, Barlow J, Holmes AH, Johnson A, Robotham JV. Quantifying drivers of antibiotic resistance in humans: a systematic review. The Lancet Infectious Diseases. 2018 Aug 29.

Scott S, D'Alessandro U, Kendall L, Bradley J, Bojang K, Correa S, Njie F, Conteh L, COSMIC Consortium. Community-based malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment with Sulfadoxinepyrimethamine: A Multicentre (The Gambia, Burkina Faso and Benin) Cluster Randomised Controlled Trial. Clinical Infectious Diseases. 2018 Jun 29.

Ginsburg O, Rositch AF, Conteh L, Mutebi M, Paskett ED, Subramanian S. Breast Cancer Disparities Among Women in Low-and Middle-Income Countries. Current Breast Cancer Reports. 2018 Sep 1;10(3):179-86.

McRobie E, Matovu F, Nanyiti A, Nonvignon J, Abankwah DN, Case KK, Hallett TB, Hanefeld J, Conteh L. National responses to global health targets: exploring policy transfer in the context of the UNAIDS ‘90–90–90’treatment targets in Ghana and Uganda.

Health Policy and Planning. 2017 Oct 11;33(1):17-33.

Weldon SM, Kelay T, Ako E, Cox B, Bello F, Kneebone R. Sequential simulation used as a novel educational tool aimed at healthcare managers: a patient-centred approach. BMJ Simulation and Technology Enhanced Learning. 2018 Jan 1;4(1):13-8.

Ahmed I, Ahmad NS, Ali S, Ali S, George A, Danish HS, Uppal E, Soo J, Mobasheri MH, King D, Cox B. Medication Adherence Apps: Review and Content Analysis. JMIR mHealth and uHealth. 2018 Mar;6(3).

Imperial College Business School

Page 12 of 16

Centre for Health Economics & Policy Innovation 17. Wahid AS, Sayma M, Jamshaid S, Kerwat DA, Oyewole F, Saleh D, Ahmed A, Cox B, Perry C, Payne S. Barriers and facilitators influencing death at home: a meta-ethnography. Palliative Medicine. 2018 Feb;32(2):314-28.

18. Weston D, Hauck K, Amlôt R. Infection prevention behaviour and infectious disease modelling: a review of the literature and recommendations for the future. BMC Public Health. 2018 Dec;18(1):336.

19. Friebel R, Hauck K, Aylin P, Steventon A. National trends in emergency readmission rates: a longitudinal analysis of administrative data for England between 2006 and 2016. BMJ Open. 2018 Mar 1;8(3):e020325.

20. Friebel R, Hauck K, Aylin P. Centralisation of acute stroke services in London: Impact evaluation using two treatment groups.

Health Economics. 2018 Apr;27(4):722-32.

21. Lau K, Hauck K, Miraldo M. Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England. Health Economics. 2019 Feb;28(2):175-88.

22. Goiana-Da-Silva F, Nunes AM, Miraldo M, Bento A, Breda J, Araujo FF. Taxation in Public Health Service: The Experience in Taxation of Sugary Drinks in Portugal (vol 4, pg 233, 2018). Acta Medica Portuguesa. 2018 Apr 1;31(4):233-.

23. Goiana-da-Silva F, Nunes AM, Miraldo M, Bento A, Breda J, Araújo FF. Using Pricing Policies to Promote Public Health: The Sugar Sweetened Beverages Taxation Experience in Portugal. Acta Medica Portuguesa. 2018 Apr 30;31(4):191-5.

24. Goiana-da-Silva F, Cruz-e-Silva D, Gregório MJ, Miraldo M, Darzi A, Araújo F. The future of the sweetened beverages tax in Portugal. The Lancet Public Health. 2018 Dec 1;3(12):e562.

25. Shaikh M, Miraldo M, Renner AT. Waiting time at health facilities and social class: Evidence from the Indian caste system. PLoS ONE. 2018 Oct 15;13(10):e0205641.

26. Miraldo M, Propper C, Williams RI. The impact of publicly subsidised health insurance on access, behavioural risk factors and disease management. Social Science & Medicine. 2018 Nov 1;217:135-51.

27. Smit M, Olney J, Ford NP, Vitoria M, Gregson S, Vassall A, Hallett TB. The growing burden of noncommunicable disease among persons living with HIV in Zimbabwe. AIDS (London, England). 2018 Mar 27;32(6):773.

28. Olney JJ, Eaton JW, Braitstein P, Hogan JW, Hallett TB. Optimal timing of HIV home-based counselling and testing rounds in Western Kenya. Journal of the International AIDS Society. 2018 Jun;21(6):e25142.

29. Propper C. Competition in health care: lessons from the English experience. Health Economics, Policy and Law. 2018:1-7.

30. de Preux L, Rizmie D. Beyond financial efficiency to support environmental sustainability in economic evaluations. Future Hospital Journal. 2018 Jun 1;5(2):103-7.

31. Sassi F, Belloni A, Mirelman AJ, Suhrcke M, Thomas A, Salti N, Vellakkal S, Visaruthvong C, Popkin BM, Nugent R. Equity impacts of price policies to promote healthy behaviours. The Lancet. 2018 Apr 5.

32. Nugent R, Bertram MY, Jan S, Niessen LW, Sassi F, Jamison DT, Pier EG, Beaglehole R. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. The Lancet. 2018 Apr 5.

33. Pimpin L, Retat L, Fecht D, de Preux L, Sassi F, Gulliver J, Belloni A, Ferguson B, Corbould E, Jaccard A, Webber L. Estimating the costs of air pollution to the National Health Service and social care: An assessment and forecast up to 2035. PLoS Medicine.

2018 Jul 10;15(7):e1002602.

34. Laiteerapong N, Cooper JM, Skandari MR, Clarke PM, Winn AN, Naylor RN, Huang ES. Individualized Glycemic Control for US Adults With Type 2 Diabetes. Annals of Internal Medicine. 2018;168:170-8.

35. Wan W, Skandari MR, Minc A, Nathan AG, Winn A, Zarei P, O’Grady M, Huang ES. Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: the DIAMOND randomized trial.

Diabetes Care. 2018 Mar 19:dc171821.

36. Wan W, Skandari MR, Minc A, Nathan AG, Zarei P, Winn AN, O’Grady M, Huang ES. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Medical Decision Making. 2018 Nov;38(8):942-53.

37. Laudicella M, Walsh B, Burns E, Donni PL, Smith PC. What is the impact of rerouting a cancer diagnosis from emergency presentation to GP referral on resource use and survival? Evidence from a population-based study. BMC Cancer. 2018 Dec;18(1):394.

38. Chi YL, Gad M, Bauhoff S, Chalkidou K, Megiddo I, Ruiz F, Smith P. Mind the costs, too: towards better cost-effectiveness analyses of PBF programmes. BMJ Global Health. 2018 Oct 1;3(5):e000994.

39. Laudicella M, Martin S, Li Donni P, Smith PC. Do Reduced Hospital Mortality Rates Lead to Increased Utilization of Inpatient Emergency Care? A Population-Based Cohort Study. Health Services Research. 2018 Aug;53(4):2324-45.

40. Cecchini M, Smith P. Assessing the dose-response relationship between number of office-based visits and hospitalizations for patients with type II diabetes using generalized propensity score matching. PLoS ONE. 2018 Dec 20;13(12):e0209197.

41. Schaefer R, Thomas R, Nyamukapa C, Maswera R, Kadzura N, Gregson S. Accuracy of HIV risk perception in East Zimbabwe 2003–2013. AIDS and Behavior. 2018 Dec 19:1-1.

42. Morton A, Arulselvan A, Thomas R. Allocation rules for global donors. Journal of Health Economics. 2018 58:67-75.

43. Thomas R, Burger R, Hauck K. Richer, wiser and in better health? The socioeconomic gradient in hypertension prevalence, unawareness and control in South Africa. Social Science & Medicine. 2018 Nov 1;217:18-30.

Book chapters 1. Miraldo M and Barrenho E. R&D Success in Pharmaceutical Markets: a duration model approach. In Baltagi BH, Moscone F (eds.). Health Econometrics in Contributions to Economic Analysis. Emerald Publishing, Emerald Publishing Limited, U.K., Chapter 9, pp. 201-235 ISBN: 9781787145429.

2. Miraldo M, Harrison GW, Galizzi MM. Experimental methods and behavioural insights: risk and time preferences in health. In Baltagi BH, Moscone F (eds.). Health Econometrics in Contributions to Economic Analysis. Emerald Publishing, Emerald Publishing Limited, U.K., Chapter 1, pp. 1-21 ISBN: 9781787145429.

Imperial College Business School

Page 13 of 16

Centre for Health Economics & Policy Innovation

Our programmes MSc International Health Management Programme Director: Dr Benita Cox Duration: One year Since 2005, our MSc in International Health Management has been providing students with the essential skills needed to springboard them into a management career in the global healthcare sector. In the 2018/2019 academic year we had 71 students in our cohort, 73% of which were female, and 63% were from outside of the European Union.

Doctoral candidates Programme Director: Prof. Carol Propper Duration: Five years CHEPI currently has 7 PhD students supervised by members of its faculty. The five-year fully funded programme managed by Imperial College Business School has significantly added to growing body of research generated by CHEPI.

Surname

Name

Topic

Primary Supervisor

Secondary Supervisor

Gressier

Mathilde

Impact of food product reformulation on population health

Prof. Franco Sassi

Prof. Gary Frost (FoM)

Hansen

Christa

Economic impacts of HIV in sub-Saharan Africa

Dr Marisa Miraldo

Dr Katharina Hauck

Lau

Krystal

Influenza pandemics and the economics of flu vaccination behaviour

Dr Marisa Miraldo

Dr Katharina Hauck

Rizmie

Dheeya

Environmental risk factors, health systems and healthy lifestyle factors

Dr Marisa Miraldo

Dr Laure de Preux

Segal

Alexa

Impact of childhood obesity on future human capital development

Prof. Franco Sassi

Dr Marisa Miraldo

Simmons

Bryony

Impact of access to medicine policies in low and middle-income countries

Prof. Graham Cooke (FoM)

Dr Marisa Miraldo

Zhu

Zhengnan

Patient movement, prescription behaviour and innovation diffusion

Dr Marisa Miraldo

Dr Renáta Kosová

Executive Education Two open and two customised programmes offered in 2018-19.

Over the last year our faculty have led and contributed to teaching several executive education programmes, including “From Idea to Health Business" in partnership with KU Leuven and Vlerick Business School, and the "Advanced Management Programme on Health Innovation" in partnership with Copenhagen Business School and IESE Business School. Both of the above were led by Prof. James Barlow and both were designed as open enrolment programmes. Prof. Barlow was also responsible for the Dubai Health Authority Executive Programme and for the Health Intrapreneurs Programme with Imperial College Health Partners.

CHEPI also received funding from EIT Health to develop a training programme for city- and national-level public health professionals entitled “Drink Up: How to Create Demand for Healthy Consumption” in 2020, based on the successful Drink Up social marketing campaign in the United States.

Imperial College Business School

Page 14 of 16

Centre for Health Economics & Policy Innovation

Imperial College Business School South Kensington Campus London SW7 2AZ United Kingdom T: +44 (0)20 7594 9173 E: health.economics@imperial.ac.uk Imperial W: imperial.ac.uk/business-school/health-economics College Business School

Page 15 of 16

Centre for Health Economics & Policy Innovation

Imperial College Business School

Page 16 of 16